Lee McDermott
Impact in
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing
- Nephrology top 5%
- Acute Kidney Injury Research
- Chronic Kidney Disease and Diabetes
Papers in
-
- Biochemical and Molecular Research 4
- Angiogenesis and VEGF in Cancer 3
- Fibroblast Growth Factor Research 3
- ATP Synthase and ATPases Research 2
-
- Cancer, Hypoxia, and Metabolism 7
- Co-authors
- Neil A. Hukriede (4 shared papers)David R. Snydman (1 shared paper)Lizzie J. Harrell (1 shared paper)Victor L. Yu (1 shared paper)Arthur J. Morris (1 shared paper)M. Hong Nguyen (1 shared paper)M Wagener (1 shared paper)Takuto Chiba (3 shared papers)
- Journals
- Journal of Biological Chemistry (3 papers)American Journal of Physiology-Renal Physiology (2 papers)Bioorganic & Medicinal Chemistry (2 papers)Oncotarget (2 papers)Clinical Infectious Diseases (1 paper)
- Partner nations
- United StatesItalyIndia
In The Last Decade
Lee McDermott
21 papers receiving 986 citations
Peers
Comparison fields: 5 of 88
- Clinical Biochemistry 150
- Nephrology 147
- Cancer Research 216
- Molecular Biology 620
- Applied Microbiology and Biotechnology 16
Countries citing papers authored by Lee McDermott
This map shows the geographic impact of Lee McDermott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee McDermott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee McDermott more than expected).
Fields of papers citing papers by Lee McDermott
This network shows the impact of papers produced by Lee McDermott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee McDermott. The network helps show where Lee McDermott may publish in the future.
Co-authors
The 25 scholars most cited alongside Lee McDermott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 180 | |
| 2 | 2000 | 164 | |
| 3 | 2013 | 153 | |
| 4 | 2014 | 88 | |
| 5 | 2018 | 68 | |
| 6 | 2013 | 60 | |
| 7 | 2016 | 47 | |
| 8 | 2015 | 45 | |
| 9 | 2015 | 27 | |
| 10 | 2015 | 26 | |
| 11 | 2021 | 24 | |
| 12 | 2013 | 23 | |
| 13 | 2005 | 17 | |
| 14 | 2017 | 16 | |
| 15 | 2018 | 14 | |
| 16 | 2017 | 13 | |
| 17 | 2019 | 12 | |
| 18 | 2019 | 8 | |
| 19 | 2015 | 6 | |
| 20 | 2004 | 3 |
About Lee McDermott
Lee McDermott is a scholar working on Molecular Biology, Cancer Research, Rheumatology, Materials Chemistry and Nephrology, having authored 22 papers that have together received 996 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (7 papers), Biochemical and Molecular Research (4 papers), Angiogenesis and VEGF in Cancer (3 papers), Fibroblast Growth Factor Research (3 papers), Folate and B Vitamins Research (3 papers), Enzyme Structure and Function (3 papers), Cancer Research and Treatments (2 papers) and ATP Synthase and ATPases Research (2 papers). The work is most often cited by research in Clinical Biochemistry (150 citations), Nephrology (147 citations), Cancer Research (216 citations), Molecular Biology (620 citations) and Applied Microbiology and Biotechnology (16 citations). Lee McDermott has collaborated with scholars based in United States, Italy and India. Frequent co-authors include Neil A. Hukriede, David R. Snydman, Lizzie J. Harrell, Victor L. Yu, Arthur J. Morris, M. Hong Nguyen, M Wagener, Takuto Chiba, Tatiana Novitskaya and Mark P. de Caestecker. Their work appears in journals such as Journal of Biological Chemistry, American Journal of Physiology-Renal Physiology, Bioorganic & Medicinal Chemistry, Oncotarget and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.